For practices
Strengthen diabetes care in your practice, with an endocrinologist and diabetes educator behind you.
eCARE brings endocrinologist and diabetes educator support, practical tools and education into your practice through a model designed to build — not replace — local capability.

Why your practice should say yes
When every attending patient is tested with an annual HbA1c, around one in five turns out to have type 2 diabetes — far more than most practices have on their register, and more than any rural practice can get timely specialist input for. eCARE closes that gap and leaves the capability behind when the trial ends.
Based on published Western Sydney Diabetes research in Western Sydney; prevalence is higher again in many rural areas. Seewesternsydneydiabetes.com.au.
Your patient stays your patient
No referral out, no waiting list, no losing track. The specialist joins your consultation; you keep the relationship and the plan.
Every diabetes patient in your practice benefits
Case conferencing is teaching in disguise. Each one brings your team up to date on current therapy and technology — and that judgement carries straight over to the hundreds of diabetes patients who never enter the trial.
You are paid for the work
$2,000 to the practice, $500 to each participating GP, and usual MBS billing for case conferencing on top.
Someone else does the study admin
A clinical trial coordinator handles recruitment support, REDCap entry, onboarding and follow-up when your team is stretched.
Tools you could not otherwise offer
CGM sensors, a patient app with food photos and coaching, and a clinician dashboard — supplied by the trial at no cost to patients or practice.
Results already published
This is not an experiment on your patients. The Western Sydney model it is built on has peer-reviewed outcomes; eCARE tests how well they travel.
And you help make the case for keeping it
Rural general practice needs this support funded properly, not trialled and withdrawn. Every practice that takes part strengthens the evidence we put to government that this model is affordable and worth building into the system permanently.
What participating practices receive
$2,000
Practice reimbursement
For your practice’s time and services across the study.
$500
Per participating GP
To cover the cost of seeing study patients.
MBS
Usual billing applies
Usual MBS billing for case conferencing, in addition to reimbursement.
- An initial virtual case conference for each patient, plus one or more follow-up sessions over several months, linking the patient and GP with an endocrinologist and diabetes educator.
- Patient-centred management plans agreed with the patient and the usual care team.
- CGM before case conferencing, and intermittently when clinically appropriate.
- Educator support through Western NSW and Western Sydney diabetes services.
- Diabetes Together app and clinician dashboard, a curated video library, myINTERACT resources and the NADC Diabetes Care Course.
- Practice audits, six-month diabetes-management reviews, specialist advice and regular feedback.
What your practice is asked to do
From first conversation to final review — largely integrated into routine clinical workflow, since much of the information is already collected as part of usual diabetes care.
- 1Nominate a practice lead and complete short GCP and protocol training.
- 2Identify potentially eligible patients with type 2 diabetes from your own list.
- 3Introduce the study briefly during routine consultations and hand out study materials.
- 4Support the consent process — in clinic, or remotely by REDCap eConsent.
- 5Enrol participants and record baseline and follow-up data in REDCap.
- 6Help patients get set up with CGM and the Diabetes Together app.
- 7Join the initial virtual case conference and the follow-up sessions, and implement the agreed care plans.
- 8Take part in follow-up reviews at 3, 6 and 9 months, and in the six-monthly practice audits.
- 9Report any serious adverse events to the study team within 24 hours.
The support you get
- Posters, flyers and QR codes to help with recruitment.
- Clear eligibility criteria and step-by-step guidance.
- A dedicated contact person for any question, at any point.
- GCP and study protocol training for your team.
- A Clinical Trial Coordinator who can help with REDCap entry, onboarding and follow-up if your team is stretched.
- CGM setup and upskilling, and Certified Diabetes Educator support after case conferences.
When would we start?
Every practice begins in the control phase, collecting agreed data on participating patients, and transitions to the intervention at its allocated period. Your first specialist case conference may fall early, midway or later in the trial.
Clinics are told their start period in advance, and no extra administrative action is needed at the transition. Once your practice starts, it continues for the rest of the trial — no practice misses out.
What eCARE is — and what it is not
eCARE is an add-on, not a replacement. All usual GP, hospital and LHD diabetes services continue unchanged, and existing referral pathways stay exactly as they are.
eCARE is
- Centred on the GP–patient relationship.
- Designed to build capability across the whole practice team.
- Supported by an endocrinologist and diabetes educator without transferring care away from the GP.
- Structured, time-limited and focused on skill transfer.
- Evaluated as part of a NSW Health funded research trial.
eCARE is not
- A replacement for existing GP or hospital services.
- A one-off specialist consultation.
- A permanent program at scale — it is a time-limited trial.
- A pathway for urgent or unstable cases; use your existing referral routes.
Is my practice eligible?
- Any general practice in the Western NSW Local Health District can take part.
- Patients you enrol should be 18 or over, have type 2 diabetes, and a recent HbA1c above 7.5%.
- No previous research experience is needed — all training and study support is provided.
Practice questions
The questions practice managers, nurses and GPs ask us first. If yours is not here, ask before you commit — we would rather answer it now.
How much extra work is this for our staff?
Expect short online training for the practice lead and participating GPs, around an hour of clinician time per case conference, and REDCap data entry at baseline and follow-up — much of which (pathology, clinical measures) you already collect in usual diabetes care. The Clinical Trial Coordinator can take on REDCap entry, onboarding and follow-up if your practice is short on capacity.
How long does the study run, and how long are we in it?
The study spans 18 months, beginning with an 8-week phased implementation period during which participating GPs complete Good Clinical Practice and protocol training. Each patient is screened and enrolled during the control phase and continues as the practice transitions to the intervention; the intervention itself runs at least 4–6 months, with research follow-up continuing for 16 months from enrolment.
When will our practice start the intervention?
Clinics are randomly allocated an order and “step” into the intervention at pre-defined intervals until all clinics are participating. You are told your allocated start period in advance, and no additional administrative action is required from your staff at the transition.
Who finds the patients?
Your practice does — through routine care or a review of practice records against the eligibility criteria. The GP or practice nurse introduces the study and provides the Participant Information Sheet. Around 20 patients per practice is the target, and the study team supports screening, invitations and enrolment throughout.
How do patients consent, and who manages the data?
Patients can complete an electronic consent form via a REDCap link or QR code, or review a printed Participant Information and Consent Form. Consent may be completed in clinic or remotely, in line with ethics approval, with time to consider and interpreter services available. Study data is stored securely in REDCap, a NSW Health approved system, under ethics and data governance requirements.
What data is collected?
Demographic and clinical information relevant to diabetes care, patient-reported outcomes such as quality of life and diabetes distress surveys, and platform and device usage data from Diabetes Together and CGM where applicable.
Can we bill MBS items?
Yes — usual MBS billing applies for case conferencing, in addition to study reimbursement. Applicable item numbers and how they are used in eCARE are confirmed with your practice before your start date.
How are reimbursements paid?
Practices are reimbursed up to $2,000 for supporting study-related activities, and each participating GP receives $500 personally. You will receive a link to register as a vendor with WNSWLHD; once registered you submit your invoice directly, or with help from the study coordinator.
Is there any cost to the clinic or our patients?
No. There is no cost to GP clinics or patients for taking part.
Can our clinic withdraw?
Yes. If the clinic withdraws before baseline there is no fee. If withdrawal occurs after baseline, a $500 termination fee applies.
What happens after the study ends?
Patients continue their usual diabetes care with their GP, and all clinical decisions remain the treating GP’s. Access to study-specific tools ceases at the end of the study unless separately incorporated into routine care. Findings are reported in aggregate with no identifiable patient information, and shared back with participating practices.
Who do we contact with questions?
A dedicated member of the eCARE research team is your primary point of contact for all study queries, with contact details in the study information pack and site documentation. You can also email the team directly from the Register page.
Interested? What happens next
There is no obligation at this stage — the next step is simply to find out more. Participation is voluntary and subject to trial eligibility and scheduling.
